CoverTip Safety Syringes Delivered to Medisys Sales Force.Business Editors & Health Writers BEDMINSTER, N.J.--(BW HealthWire)--Oct. 25, 2000 Medisys Technologies, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : SCEP SCEP Student Career Experience Program SCEP Simple Certificate Enrollment Protocol (Cisco) SCEP Syndicat Canadien des Communications, de l'Énergie et du Papier (Communications, Energy and Paperworkers Union) ) has received and delivered an initial shipment of its proprietary CoverTip(TM) hypodermic hypodermic /hy·po·der·mic/ (-der´mik) applied or administered beneath the skin. hy·po·der·mic adj. 1. Of or relating to the layer just beneath the epidermis. 2. safety syringe to its sales force at strategic locations in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Spurred by recent federal and state regulations to protect healthcare workers from accidental needlesticks, Medisys is now introducing CoverTip into the multi-billion dollar syringe market. Medisys believes that its device makes available to the marketplace the premier hypodermic syringe hypodermic syringe n. A syringe with a calibrated barrel, plunger, and tip, used with a hypodermic needle for hypodermic injections and for aspiration. providing affordable protection to nurses and technicians at risk. "We are pleased to report that we are on schedule for the rollout of CoverTip," reported Kerry Frey, President and COO of Medisys Technologies. "Medisys' Development Engineer, Gary Schneberger is currently at the manufacturing facility, Dispomedic 2000, in Israel where he reports producti on is moving along as planned." About CoverTip(TM) Medisys Technologies Inc. has successfully developed and had subsequently been granted FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. 510K clearance to market its patented CoverTip(TM) safety needle device which the company believes provides superior protection against accidental needlesticks. CoverTip is used just as any standard syringe with insertion of the needle into the patient's skin and depression of the syringe plunger to inject the medicine. A micro-thin sheathe sheathe tr.v. sheathed, sheath·ing, sheathes 1. To insert into or provide with a sheath. 2. To retract (a claw) into a sheath. 3. To enclose with a protective covering; encase. covers the tip of the needle after injection of the medical fluid. When the syringe plunger is pressed and the medicinal fluid injected, the plunger contacts an actuator that engages the sleeve that locks over and blunts the tip of the needle, providing protection prior to the removal of the needle from the patient's skin. About Medisys Technologies Medisys Technologies, Inc. is a diversified medical company that develops, manufactures and markets patented products for improving safety and patient care. Spurred by recent Federal Regulations and State Safety Legislation Medisys is currently concentrating on commercializing its portfolio of patented needle safety technology, with unique features and competitive advantages over other safety devices. In addition to the CoverTip hypodermic syringe, the Medisys portfolio of patented safety devices includes: BXDraw(TM), a fine needle biopsy/aspiration safety syringe; SofDraw(TM), a blood and fluid collection safety syringe; and MultiDraw(TM), a needleless multiple vacuum vial blood collection safety device. The Company has a total of 19 patent applications for new safety designs in blood collection, capillary blood testing, and tissue excision cutting needles and has granted 510K clearance by the FDA to market its products. For more information about Medisys Technology and its proprietary suite of needle safety technologies, please contact Shayne Payne, Juan Dominguez or Dian Griesel, Ph.D. at the Investor Relations Investor relations The process by which the corporation communicates with its investors. Group: 212 736 2650 or visit us on the web at www.medisystech.com Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: Except for historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including but not limited to economic, competitive, governmental and technological factors affecting the Company's operations, markets, products and prices and other factors discussed in the Company's various filings with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion